The efficacy of gemtuzumab ozogamicin in patients with acute leukemia: a single center experience

被引：0
|
作者：
Hosono, Naoko [1 ]
Yamauchi, Takahiro [1 ]
Matsuda, Yasufumi [1 ]
Kishi, Shinji [1 ]
Urasaki, Yoshimasa [1 ]
Yoshida, Akira [1 ]
Ueda, Takanori [1 ]
机构：
[1] Univ Fukui, Fac Med Sci, Dept Hematol & Oncol, Fukui, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-11-2
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia
    Arceci, RJ
    Sande, J
    Lange, B
    Shannon, K
    Franklin, J
    Hutchinson, R
    Vik, TA
    Flowers, D
    Aplenc, R
    Berger, MS
    Sherman, ML
    Smith, FO
    Bernstein, I
    Sievers, EL
    BLOOD, 2005, 106 (04) : 1183 - 1188
  • [32] Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
    Lo-Coco, F
    Cimino, G
    Breccia, M
    Noguera, NI
    Diverio, D
    Finolezzi, E
    Pogliani, EM
    Di Bona, E
    Micalizzi, C
    Kropp, M
    Venditti, A
    Tafuri, A
    Mandelli, F
    BLOOD, 2004, 104 (07) : 1995 - 1999
  • [33] Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.
    Stadtmauer E.A.
    Current Oncology Reports, 2002, 4 (5) : 375 - 380
  • [34] Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults
    Goldenson, Benjamin H.
    Goodman, Aaron M.
    Ball, Edward D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 849 - 862
  • [35] Gemtuzumab Ozogamicin In Refractory Childhood Acute Myeloid Leukemia
    Reinhardt, Dirk
    Zwaan, Christian M.
    Sander, Annette
    Neuhoff, Christine
    Kaspers, Gertjan J.
    Creutzig, Ursula
    BLOOD, 2010, 116 (21) : 470 - 470
  • [36] Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
    Gottardi, Michele
    Simonetti, Giorgia
    Sperotto, Alessandra
    Nappi, Davide
    di Rora, Andrea Ghelli Luserna
    Padella, Antonella
    Norata, Marianna
    Giannini, Maria Benedetta
    Musuraca, Gerardo
    Lanza, Francesco
    Cerchione, Claudio
    Martinelli, Giovanni
    CANCERS, 2021, 13 (18)
  • [37] The Evolving Use of Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
    Walter, Roland B.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 152 - 154
  • [38] Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia
    Parigger, J.
    Zwaan, C. M.
    Reinhardt, D.
    Kaspers, G. J. L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 137 - 146
  • [39] Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)
    Takeshita, Akihiro
    Ono, Takaaki
    Kojima, Yumi
    Kyo, Taiichi
    Asou, Norio
    Suzushima, Hitoshi
    Yagasaki, Fumiharu
    Maeda, Tomoya
    Okada, Masaya
    Nakaseko, Chiaki
    Kanbayashi, Hiroyuki
    Yamaguchi, Masaki
    Kurosawa, Mitsutoshi
    Tsuboi, Kosuke
    Yujiri, Toshiaki
    Nannya, Yasuhito
    Uike, Naokuni
    Akiyama, Nobu
    Fukuda, Tetsuya
    Karimata, Kaori
    Okumura, Hirokazu
    Eto, Tetsuya
    Izumiyama, Koh
    Watanabe, Akihiro
    Aotsuka, Nobuyuki
    Ito, Katsuro
    Ozaki, Keiji
    Naoe, Tomoki
    BLOOD, 2011, 118 (21) : 665 - 666
  • [40] Outcomes of Extramedullary Acute Myeloid Leukemia with Gemtuzumab Ozogamicin: Real-World Experience
    Patel, Riya
    Shalaby, Khalid
    Roche, Charles
    Awada, Hassan
    Griffiths, Elizabeth A.
    Thompson, James E.
    Green, Steven
    Sung, Pamela Jeannette
    Wang, Eunice S.
    Przespolewski, Amanda C.
    BLOOD, 2023, 142
12345